Higher Risks for Artificially Conceived Infants
By Miriam Zoll, <i>Biopolitical Times</i> guest contributor
| 03. 12. 2014
Data about the risks involved in high-tech assisted reproduction have until recently been scarce. The industry naturally touts success rates and downplays failures, and the Centers for Disease Control and Prevention (CDC) has largely been restricted to sharing only self-reported data from clinics with the public. But this is changing—and families intending to use these technologies should be aware of the full implications of the statistics that are available.
Last month, for instance, the Society for Assisted Reproductive Technologies announced that a record number of babies were born – 61,740 – as a result of the 165,172 in vitro fertilization (IVF) cycles performed at 379 of its member clinics in 2012.1
On the surface, this announcement may be perceived as an endorsement for the success of reproductive medical services that have, undoubtedly, helped many couples over the last 35 years to bear the children they might otherwise not have been able to. As we celebrate the births of these babies, however, it is also important to recognize that the vast majority of IVF cycles continue to fail, and that...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...